Could stem cell exosomes restore fertility? new trial tests hope for early ovarian failure
NCT ID NCT07510139
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether exosomes from umbilical cord stem cells can help women with premature ovarian insufficiency (early menopause). The treatment aims to improve ovarian function and quality of life. About 60 women aged 20-39 will receive the experimental therapy, and researchers will monitor safety and hormone levels.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE OVARIAN INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
International Peace Maternity & Child Health Hospital
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Major study launches to unravel mysteries of early menopause
- DNA hunt for why some women face early menopause
- Stem cell shot into ovaries aims to tame perimenopause symptoms
- Could pollution and sleep habits be messing with your hormones? new study investigates.
- Early menopause heart risk under microscope: hormone Therapy's role questioned
- Microbiome clues in early ovarian failure: study compares bacteria in women with POI and healthy controls